US 12,269,820 B2
Piperazine substituted indazole compounds as inhibitors of PARG
Paul A. Barsanti, South San Francisco, CA (US); Michael Patrick Dillon, South San Francisco, CA (US); Firoz Ali Jaipuri, South San Francisco, CA (US); Ying-Zi Xu, South San Francisco, CA (US); and Xin Linghu, South San Francisco, CA (US)
Assigned to IDEAYA Biosciences, Inc., South San Francisco, CA (US)
Filed by IDEAYA BIOSCIENCES, INC., South San Francisco, CA (US)
Filed on Mar. 22, 2023, as Appl. No. 18/188,278.
Claims priority of provisional application 63/322,994, filed on Mar. 23, 2022.
Prior Publication US 2023/0303556 A1, Sep. 28, 2023
Int. Cl. C07D 417/14 (2006.01); A61P 35/00 (2006.01)
CPC C07D 417/14 (2013.01) [A61P 35/00 (2018.01)] 12 Claims
 
1. A compound of Formula (I):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.